Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.

Kim ST, Cristescu R, Bass AJ, Kim KM, Odegaard JI, Kim K, Liu XQ, Sher X, Jung H, Lee M, Lee S, Park SH, Park JO, Park YS, Lim HY, Lee H, Choi M, Talasaz A, Kang PS, Cheng J, Loboda A, Lee J, Kang WK.

Nat Med. 2018 Jul 16. doi: 10.1038/s41591-018-0101-z. [Epub ahead of print]

PMID:
30013197
2.

The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.

Zill OA, Banks KC, Fairclough SR, Mortimer SA, Vowles JV, Mokhtari R, Gandara DR, Mack PC, Odegaard JI, Nagy RJ, Baca AM, Eltoukhy H, Chudova DI, Lanman RB, Talasaz A.

Clin Cancer Res. 2018 May 18. doi: 10.1158/1078-0432.CCR-17-3837. [Epub ahead of print]

PMID:
29776953
3.
4.

Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies.

Odegaard JI, Vincent JJ, Mortimer S, Vowles JV, Ulrich BC, Banks KC, Fairclough SR, Zill OA, Sikora M, Mokhtari R, Abdueva D, Nagy RJ, Lee CE, Kiedrowski LA, Paweletz CP, Eltoukhy H, Lanman RB, Chudova DI, Talasaz A.

Clin Cancer Res. 2018 Apr 24. doi: 10.1158/1078-0432.CCR-17-3831. [Epub ahead of print]

PMID:
29691297
5.

Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma.

Ikeda S, Tsigelny IF, Skjevik ÅA, Kono Y, Mendler M, Kuo A, Sicklick JK, Heestand G, Banks KC, Talasaz A, Lanman RB, Lippman S, Kurzrock R.

Oncologist. 2018 May;23(5):586-593. doi: 10.1634/theoncologist.2017-0479. Epub 2018 Feb 27.

PMID:
29487225
6.

Two-year Follow-up of Patients With Unstable Angina/Non-ST Segment Elevation Myocardial Infarction Undergoing Early Invasive Strategy: Predictors of Normal or Near-Normal Coronary Angiography and Mortality.

Jenab Y, Kassaian E, Pourhosseini HR, Salarifar M, Jalali A, Talasaz AH.

Crit Pathw Cardiol. 2018 Mar;17(1):47-52. doi: 10.1097/HPC.0000000000000108.

PMID:
29432377
7.

Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients.

Kim ST, Banks KC, Pectasides E, Kim SY, Kim K, Lanman RB, Talasaz A, An J, Choi MG, Lee JH, Sohn TS, Bae JM, Kim S, Park SH, Park JO, Park YS, Lim HY, Kim NKD, Park W, Lee H, Bass AJ, Kim K, Kang WK, Lee J.

Ann Oncol. 2018 Apr 1;29(4):1037-1048. doi: 10.1093/annonc/mdy034.

8.

Protection from Reperfusion Injury with Intracoronary N-Acetylcysteine in Patients with STEMI Undergoing Primary Percutaneous Coronary Intervention in a Cardiac Tertiary Center.

Nozari Y, Eshraghi A, Talasaz AH, Bahremand M, Salamzadeh J, Salarifar M, Pourhosseini H, Jalali A, Mortazavi SH.

Am J Cardiovasc Drugs. 2018 Jun;18(3):213-221. doi: 10.1007/s40256-017-0258-8.

PMID:
29322434
9.

Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer.

Strickler JH, Loree JM, Ahronian LG, Parikh AR, Niedzwiecki D, Pereira AAL, McKinney M, Korn WM, Atreya CE, Banks KC, Nagy RJ, Meric-Bernstam F, Lanman RB, Talasaz A, Tsigelny IF, Corcoran RB, Kopetz S.

Cancer Discov. 2018 Feb;8(2):164-173. doi: 10.1158/2159-8290.CD-17-1009. Epub 2017 Dec 1.

PMID:
29196463
10.

Effect of memantine on post-operative cognitive dysfunction after cardiac surgeries: a randomized clinical trial.

Ghaffary S, Ghaeli P, Talasaz AH, Karimi A, Noroozian M, Salehiomran A, Jalali A.

Daru. 2017 Nov 21;25(1):24. doi: 10.1186/s40199-017-0190-0.

11.

Effect of High-Dose Allopurinol Pretreatment on Cardiac Biomarkers of Patients Undergoing Elective Percutaneous Coronary Intervention: A Randomized Clinical Trial.

Alemzadeh-Ansari MJ, Hosseini SK, Talasaz AH, Mohammadi M, Tokaldani ML, Jalali A, Pourhosseini H.

Am J Ther. 2017 Nov/Dec;24(6):e723-e729. doi: 10.1097/MJT.0000000000000411.

PMID:
28984632
12.

Randomized Trial of Carnitine for the Prevention of Perioperative Atrial Fibrillation.

Dastan F, Talasaz AH, Mojtahedzadeh M, Karimi A, Salehiomran A, Bina P, Jalali A.

Semin Thorac Cardiovasc Surg. 2018 Spring;30(1):7-13. doi: 10.1053/j.semtcvs.2017.08.006. Epub 2017 Aug 24.

PMID:
28982550
13.

Clinical utility of circulating cell-free DNA in advanced colorectal cancer.

Pereira AAL, Morelli MP, Overman M, Kee B, Fogelman D, Vilar E, Shureiqi I, Raghav K, Eng C, Manuel S, Crosby S, Wolff RA, Banks K, Lanman R, Talasaz A, Kopetz S, Morris V.

PLoS One. 2017 Aug 29;12(8):e0183949. doi: 10.1371/journal.pone.0183949. eCollection 2017.

14.

Genomic Alterations in Circulating Tumor DNA from Diverse Cancer Patients Identified by Next-Generation Sequencing.

Schwaederle M, Chattopadhyay R, Kato S, Fanta PT, Banks KC, Choi IS, Piccioni DE, Ikeda S, Talasaz A, Lanman RB, Bazhenova L, Kurzrock R.

Cancer Res. 2017 Oct 1;77(19):5419-5427. doi: 10.1158/0008-5472.CAN-17-0885. Epub 2017 Aug 14.

PMID:
28807936
15.

The Role of N-Acetylcysteine in Platelet Aggregation and Reperfusion Injury in Recent Years.

Nikbakht M, Ahmadi F, Vaseghi G, Talasaz AH, Eshraghi A, Naderi J, Daneshmehr MA.

Curr Clin Pharmacol. 2017;12(2):83-91. doi: 10.2174/1574884712666170704145842.

PMID:
28676007
16.

Potential Role of Allopurinol in Preventing Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Randomized Placebo-Controlled Trial.

Ghelich Khan Z, Talasaz AH, Pourhosseini H, Hosseini K, Alemzadeh Ansari MJ, Jalali A.

Clin Drug Investig. 2017 Sep;37(9):853-860. doi: 10.1007/s40261-017-0542-z.

PMID:
28608311
17.

Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma.

Schwaederlé MC, Patel SP, Husain H, Ikeda M, Lanman RB, Banks KC, Talasaz A, Bazhenova L, Kurzrock R.

Clin Cancer Res. 2017 Sep 1;23(17):5101-5111. doi: 10.1158/1078-0432.CCR-16-2497. Epub 2017 May 24.

PMID:
28539465
18.

Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.

Grossman RL, Abel B, Angiuoli S, Barrett JC, Bassett D, Bramlett K, Blumenthal GM, Carlsson A, Cortese R, DiGiovanna J, Davis-Dusenbery B, Dittamore R, Eberhard DA, Febbo P, Fitzsimons M, Flamig Z, Godsey J, Goswami J, Gruen A, Ortuño F, Han J, Hayes D, Hicks J, Holloway D, Hovelson D, Johnson J, Juhl H, Kalamegham R, Kamal R, Kang Q, Kelloff GJ, Klozenbuecher M, Kolatkar A, Kuhn P, Langone K, Leary R, Loverso P, Manmathan H, Martin AM, Martini J, Miller D, Mitchell M, Morgan T, Mulpuri R, Nguyen T, Otto G, Pathak A, Peters E, Philip R, Posadas E, Reese D, Reese MG, Robinson D, Dei Rossi A, Sakul H, Schageman J, Singh S, Scher HI, Schmitt K, Silvestro A, Simmons J, Simmons T, Sislow J, Talasaz A, Tang P, Tewari M, Tomlins S, Toukhy H, Tseng HR, Tuck M, Tzou A, Vinson J, Wang Y, Wells W, Welsh A, Wilbanks J, Wolf J, Young L, Lee J, Leiman LC.

Clin Pharmacol Ther. 2017 May;101(5):589-592. doi: 10.1002/cpt.666. Epub 2017 Apr 12. Review.

19.

The Role of Direct and Visual Force Feedback in Suturing Using a 7-DOF Dual-Arm Teleoperated System.

Talasaz A, Trejos AL, Patel RV.

IEEE Trans Haptics. 2017 Apr-Jun;10(2):276-287. doi: 10.1109/TOH.2016.2616874. Epub 2016 Oct 12.

PMID:
28113408
20.

The role of visual and direct force feedback in robotics-assisted mitral valve annuloplasty.

Currie ME, Talasaz A, Rayman R, Chu MWA, Kiaii B, Peters T, Trejos AL, Patel R.

Int J Med Robot. 2017 Sep;13(3). doi: 10.1002/rcs.1787. Epub 2016 Nov 16.

PMID:
27862833
21.

O.02: Plasma Next Generation Sequencing of Over 5,000 Advanced Non-Small Cell Lung Cancer Patients With Clinical Correlations.

Mack PC, Banks KC, Zill OA, Mortimer SA, Chudova DI, Odegaard J, Lee CE, Nagy RJ, Eltoukhy H, Talasaz A, Lanman R, Gandara DR.

J Thorac Oncol. 2016 Oct;11(10S):S168-S169. doi: 10.1016/j.jtho.2016.08.005. Epub 2016 Sep 22. No abstract available.

22.

Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.

Villaflor V, Won B, Nagy R, Banks K, Lanman RB, Talasaz A, Salgia R.

Oncotarget. 2016 Oct 11;7(41):66880-66891. doi: 10.18632/oncotarget.11801.

23.

Gene polymorphisms and the risk of warfarin-induced bleeding complications at therapeutic international normalized ratio (INR).

Pourgholi L, Goodarzynejad H, Mandegary A, Ziaee S, Talasaz AH, Jalali A, Boroumand M.

Toxicol Appl Pharmacol. 2016 Oct 15;309:37-43. doi: 10.1016/j.taap.2016.08.026. Epub 2016 Aug 28.

PMID:
27581200
24.

The effect of a single dose of vitamin D on glycemic status and C-reactive protein levels in type 2 diabetic patients with ischemic heart disease: a randomized clinical trial.

Shaseb E, Tohidi M, Abbasinazari M, Khalili D, Talasaz AH, Omrani H, Hadaegh F.

Acta Diabetol. 2016 Aug;53(4):575-82. doi: 10.1007/s00592-016-0843-3. Epub 2016 Feb 12.

PMID:
26873242
25.

Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay.

Schwaederle M, Husain H, Fanta PT, Piccioni DE, Kesari S, Schwab RB, Banks KC, Lanman RB, Talasaz A, Parker BA, Kurzrock R.

Oncotarget. 2016 Mar 1;7(9):9707-17. doi: 10.18632/oncotarget.7110.

26.

Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA.

Lanman RB, Mortimer SA, Zill OA, Sebisanovic D, Lopez R, Blau S, Collisson EA, Divers SG, Hoon DS, Kopetz ES, Lee J, Nikolinakos PG, Baca AM, Kermani BG, Eltoukhy H, Talasaz A.

PLoS One. 2015 Oct 16;10(10):e0140712. doi: 10.1371/journal.pone.0140712. eCollection 2015.

27.

Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.

Kim ST, Lee WS, Lanman RB, Mortimer S, Zill OA, Kim KM, Jang KT, Kim SH, Park SH, Park JO, Park YS, Lim HY, Eltoukhy H, Kang WK, Lee WY, Kim HC, Park K, Lee J, Talasaz A.

Oncotarget. 2015 Nov 24;6(37):40360-9. doi: 10.18632/oncotarget.5465.

28.

Evaluating the Effect of Intracoronary N-Acetylcysteine on Platelet Activation Markers After Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction.

Eshraghi A, Talasaz AH, Salamzadeh J, Salarifar M, Pourhosseini H, Nozari Y, Bahremand M, Jalali A, Boroumand MA.

Am J Ther. 2016 Jan-Feb;23(1):e44-51. doi: 10.1097/MJT.0000000000000309.

PMID:
26291594
29.

A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma.

Ko AH, Bekaii-Saab T, Van Ziffle J, Mirzoeva OM, Joseph NM, Talasaz A, Kuhn P, Tempero MA, Collisson EA, Kelley RK, Venook AP, Dito E, Ong A, Ziyeh S, Courtin R, Linetskaya R, Tahiri S, Korn WM.

Clin Cancer Res. 2016 Jan 1;22(1):61-8. doi: 10.1158/1078-0432.CCR-15-0979. Epub 2015 Aug 6.

30.

Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.

Zill OA, Greene C, Sebisanovic D, Siew LM, Leng J, Vu M, Hendifar AE, Wang Z, Atreya CE, Kelley RK, Van Loon K, Ko AH, Tempero MA, Bivona TG, Munster PN, Talasaz A, Collisson EA.

Cancer Discov. 2015 Oct;5(10):1040-8. doi: 10.1158/2159-8290.CD-15-0274. Epub 2015 Jun 24.

31.

The Effect of High-Dose Vitamin D3 on Soluble P-Selectin and hs-CRP Level in Patients With Venous Thromboembolism: A Randomized Clinical Trial.

Gholami K, Talasaz AH, Entezari-Maleki T, Salarifar M, Hadjibabaie M, Javadi MR, Dousti S, Hamishehkar H, Maleki S.

Clin Appl Thromb Hemost. 2016 Jul;22(5):483-9. doi: 10.1177/1076029614568715. Epub 2015 Jan 19.

PMID:
25601896
32.

Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.

Kim ST, Sohn I, DO IG, Jang J, Kim SH, Jung IH, Park JO, Park YS, Talasaz A, Lee J, Kim HC.

Cancer Genomics Proteomics. 2014 Sep-Oct;11(5):259-66.

PMID:
25331798
33.

Study of the possible medical and medication explanatory factors of angiographic outcomes in patients with acute ST elevation myocardial infarction undergoing primary percutaneous intervention.

Eshraghi A, Talasaz AH, Salamzadeh J, Bahremand M, Salarifar M, Nozari Y, Jenab Y, Boroumand MA, Vaseghi G, Eshraghi N.

Adv Biomed Res. 2014 Sep 4;3:186. doi: 10.4103/2277-9175.140096. eCollection 2014.

34.

Comparison of the effects of N-acetyl-cysteine and ginseng in prevention of noise induced hearing loss in male textile workers.

Doosti A, Lotfi Y, Moossavi A, Bakhshi E, Talasaz AH, Hoorzad A.

Noise Health. 2014 Jul-Aug;16(71):223-7. doi: 10.4103/1463-1741.137057.

35.

Distortion Product Otoacoustic Emission (DPOAE) as an Appropriate Tool in Assessment of Otoprotective Effects of Antioxidants in Noise-Induced Hearing Loss (NIHL).

Doosti A, Lotfi Y, Moosavi A, Bakhshi E, Talasaz AH.

Indian J Otolaryngol Head Neck Surg. 2014 Sep;66(3):325-9. doi: 10.1007/s12070-014-0721-7. Epub 2014 Apr 17.

36.

Integration of force reflection with tactile sensing for minimally invasive robotics-assisted tumor localization.

Talasaz A, Patel RV.

IEEE Trans Haptics. 2013 Apr-Jun;6(2):217-28. doi: 10.1109/TOH.2012.64.

PMID:
24808305
37.

Effects of N-acetylcysteine on the cardiac remodeling biomarkers and major adverse events following acute myocardial infarction: a randomized clinical trial.

Talasaz AH, Khalili H, Fahimi F, Jenab Y, Broumand MA, Salarifar M, Darabi F.

Am J Cardiovasc Drugs. 2014 Feb;14(1):51-61. doi: 10.1007/s40256-013-0048-x.

PMID:
24105017
38.
39.

Changes in gram negative microorganisms' resistance pattern during 4 years period in a referral teaching hospital; a surveillance study.

Khalili H, Dashti-Khavidaki S, Shahidi MR, Abdollahi A, Jafari S, Jahangard-Rafsanjani Z, Talasaz AH.

Daru. 2012 Sep 10;20(1):28. doi: 10.1186/2008-2231-20-28.

40.

The Bioavailability of Salbutamol in Urine via Volumatic and Nonvolumatic Valved Holding Chambers.

Fahimi F, Kobarfard F, Salamzadeh J, Fakharian A, Abdolahi P, Talasaz AH, Pour HM, Baniasadi S, Masjedi M.

World Allergy Organ J. 2011 Nov;4(11):179-83. doi: 10.1097/WOX.0b013e31823890f6. Epub 2011 Nov 18.

41.

mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer.

Cann GM, Gulzar ZG, Cooper S, Li R, Luo S, Tat M, Stuart S, Schroth G, Srinivas S, Ronaghi M, Brooks JD, Talasaz AH.

PLoS One. 2012;7(11):e49144. doi: 10.1371/journal.pone.0049144. Epub 2012 Nov 7.

42.

The potential role of clinical pharmacy services in patients with cardiovascular diseases.

Talasaz AH.

J Tehran Heart Cent. 2012 Spring;7(2):41-6. Epub 2012 May 31.

43.

Colorectal cancer targeted Irinotecan-Assam Bora rice starch based microspheres: a mechanistic, pharmacokinetic and biochemical investigation.

Ahmad MZ, Akhter S, Anwar M, Kumar A, Rahman M, Talasaz AH, Ahmad FJ.

Drug Dev Ind Pharm. 2013 Dec;39(12):1936-43. doi: 10.3109/03639045.2012.719906. Epub 2012 Sep 27.

PMID:
23013140
44.

Clinical characteristics and risk assessment of ST-segment elevation myocardial infarction patients of an Iranian referral center.

Khalili H, Talasaz AH, Jenab Y, Salarifar M.

J Cardiovasc Med (Hagerstown). 2012 Nov;13(11):708-15. doi: 10.2459/JCM.0b013e328356a3c6.

PMID:
22914305
45.

Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines.

Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, Deng G, Telli ML, Advani RH, Carlson RW, Mollick JA, Sheth S, Kurian AW, Ford JM, Stockdale FE, Quake SR, Pease RF, Mindrinos MN, Bhanot G, Dairkee SH, Davis RW, Jeffrey SS.

PLoS One. 2012;7(5):e33788. doi: 10.1371/journal.pone.0033788. Epub 2012 May 7.

46.

Adherence to antiretroviral therapy among Iranian HIV/AIDS patients.

Khalili H, Rohani R, Seyedalinaghi S, Hajiabdolbaghi M, Dashti-Khavidaki S, Talasaz AH.

Curr Clin Pharmacol. 2012 May;7(2):111-5.

PMID:
22432842
47.

Evaluation of the pattern of human albumin utilization at a university affiliated hospital.

Talasaz AH, Jahangard-Rafsanjani Z, Ziaie S, Fahimi F.

Arch Iran Med. 2012 Feb;15(2):85-7. doi: 012152/AIM.007.

48.

Plasma vitamin C concentrations in patients on routine hemodialysis and its relationship to patients' morbidity and mortality.

Dashti-Khavidaki S, Talasaz AH, Tabeefar H, Hajimahmoodi M, Moghaddam G, Khalili H, Lessan-Pezeshki M, Jahanmardi A.

Int J Vitam Nutr Res. 2011 Jul;81(4):197-203. doi: 10.1024/0300-9831/a000065.

PMID:
22237767
49.

Serum vitamin D concentration status and its correlation with early biomarkers of remodeling following acute myocardial infarction.

Khalili H, Talasaz AH, Salarifar M.

Clin Res Cardiol. 2012 May;101(5):321-7. doi: 10.1007/s00392-011-0394-0. Epub 2011 Dec 11.

PMID:
22159952
50.

Severe hepatotoxicity and probable hepatorenal syndrome associated with sulfadiazine.

Khalili H, Soudbakhsh A, Talasaz AH.

Am J Health Syst Pharm. 2011 May 15;68(10):888-92. doi: 10.2146/ajhp100516.

PMID:
21546639

Supplemental Content

Loading ...
Support Center